Stock Based Compensation (Details) (USD $) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 3 Months Ended
Aug. 28, 2009
| 3 Months Ended
Aug. 29, 2008
| 9 Months Ended
Aug. 28, 2009
| 9 Months Ended
Aug. 29, 2008
| 3 Months Ended
Aug. 28, 2009
Option Grants
| 3 Months Ended
Aug. 29, 2008
Option Grants
| 9 Months Ended
Aug. 28, 2009
Option Grants
| 9 Months Ended
Aug. 29, 2008
Option Grants
| 9 Months Ended
Aug. 28, 2009
2009 Program
| Nov. 28, 2008
2009 Program
| 9 Months Ended
Aug. 28, 2009
2009 Program
| Nov. 28, 2008
2009 Program
| 3 Months Ended
Aug. 28, 2009
Option Grants and Stock Purchase Rights
| | 3 Months Ended
Aug. 29, 2008
Option Grants and Stock Purchase Rights
| | 9 Months Ended
Aug. 28, 2009
Option Grants and Stock Purchase Rights
| | 9 Months Ended
Aug. 29, 2008
Option Grants and Stock Purchase Rights
| | 3 Months Ended
Aug. 28, 2009
Restricted Stock and Performance Share Awards
| | 3 Months Ended
Aug. 29, 2008
Restricted Stock and Performance Share Awards
| | 9 Months Ended
Aug. 28, 2009
Restricted Stock and Performance Share Awards
| | 9 Months Ended
Aug. 29, 2008
Restricted Stock and Performance Share Awards
| | 9 Months Ended
Aug. 28, 2009
Restricted Stock Unit
| | 12 Months Ended
Nov. 28, 2008
Restricted Stock Unit
| Aug. 29, 2008
Restricted Stock Unit
| | Nov. 30, 2007
Restricted Stock Unit
| 3 Months Ended
Aug. 28, 2009
Employee Stock Purchase Plan
| 3 Months Ended
Aug. 29, 2008
Employee Stock Purchase Plan
| 9 Months Ended
Aug. 28, 2009
Employee Stock Purchase Plan
| 9 Months Ended
Aug. 29, 2008
Employee Stock Purchase Plan
| 9 Months Ended
Aug. 28, 2009
Prior Year
| | 12 Months Ended
Nov. 28, 2008
Prior Year
| Aug. 29, 2008
Prior Year
| | Nov. 30, 2007
Prior Year
| 9 Months Ended
Aug. 28, 2009
Stock Options
| | 12 Months Ended
Nov. 28, 2008
Stock Options
| Aug. 29, 2008
Stock Options
| | Nov. 30, 2007
Stock Options
| 9 Months Ended
Aug. 28, 2009
2009 Program
| 3 Months Ended
Feb. 27, 2009
2008 Program
|
Expected Life (in years) [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
From | | | | | 3.7 | 3.5 | 3 | 2.3 | | | | | | | | | | | | | | | | | | | | | | | | | | | 0.5 | 0.5 | 0.5 | 0.5 | | | | | | | | | | | | | | |
To | | | | | 3.8 | 3.6 | 3.8 | 4.7 | | | | | | | | | | | | | | | | | | | | | | | | | | | 2 | 2 | 2 | 2 | | | | | | | | | | | | | | |
Volatility [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
From | | | | | 0.37 | 0.34 | 0.37 | 0.32 | | | | | | | | | | | | | | | | | | | | | | | | | | | 0.4 | 0.34 | 0.4 | 0.3 | | | | | | | | | | | | | | |
To | | | | | 0.43 | 0.37 | 0.57 | 0.39 | | | | | | | | | | | | | | | | | | | | | | | | | | | 0.4 | 0.36 | 0.57 | 0.36 | | | | | | | | | | | | | | |
Risk Free Interest Rate [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
From | | | | | 0.0193 | 0.0279 | 0.0116 | 0.017 | | | | | | | | | | | | | | | | | | | | | | | | | | | 0.0033 | 0.0212 | 0.0027 | 0.0212 | | | | | | | | | | | | | | |
To | | | | | 0.0224 | 0.035 | 0.0224 | 0.035 | | | | | | | | | | | | | | | | | | | | | | | | | | | 0.0105 | 0.0266 | 0.0105 | 0.0329 | | | | | | | | | | | | | | |
Stock Option Activity [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning outstanding balance | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 40,704,000 | | 47,742,000 | | | | | |
Granted | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 4,914,000 | | 5,462,000 | | | | | |
Exercised | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (4,370,000) | | (9,983,000) | | | | | |
Cancelled | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (2,699,000) | | (2,517,000) | | | | | |
Ending outstanding balance | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 38,549,000 | | 40,704,000 | 42,070,000 | | 47,742,000 | | |
Stock Options Outstanding [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Options outstanding - Shares | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 38,549,000 | | 40,704,000 | 42,070,000 | | 47,742,000 | | |
Options vested and expected to vest - Shares | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 36,986,000 | | | 39,936,000 | | | | |
Options exercisable - Shares | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 26,573,000 | | | 27,252,000 | | | | |
Options outstanding - Exercise Price | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 29.75 | | | 29.67 | | | | |
Options vested and expected to vest - Exercise Price | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 29.78 | | | 29.29 | | | | |
Options exercisable - Exercise Price | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 29.21 | | | 25.94 | | | | |
Options outstanding - Life | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 3.92 | | | 4.16 | | | | |
Options vested and expected to vest - Life | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 3.84 | | | 4.07 | | | | |
Options exercisable - Life | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 3.23 | | | 3.35 | | | | |
Options outstanding - Intrinsic Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $176,900,000 | [3] | | $554,500,000 | [3] | | | |
Options vested and expected to vest - Intrinsic Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 168,500,000 | [3] | | 541,200,000 | [3] | | | |
Options exercisable - Intrinsic Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 127,800,000 | [3] | | 460,300,000 | [3] | | | |
Restricted Stock Unit Activity [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning outstanding balance | | | | | | | | | 0 | | 0 | | | | | | | | | | | | | | | | | | 4,261,000 | | 1,701,000 | | | | | | | | 383,000 | | 0 | | | | | | | | | | | |
Awarded | | | | | | | | | 558,000 | | 642,000 | | | | | | | | | | | | | | | | | | 3,333,000 | | 3,177,000 | | | | | | | | | | | | | | | | | | | | | |
Released | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (984,000) | | (422,000) | | | | | | | | (382,000) | | (480,000) | | | | | | | | | | | |
Forfeited | | | | | | | | | (3,000) | | (4,000) | | | | | | | | | | | | | | | | | | (291,000) | | (195,000) | | | | | | | | (59,000) | | (130,000) | | | | | | | | | | | |
Ending outstanding balance | | | | | | | | | 555,000 | 0 | 638,000 | 0 | | | | | | | | | | | | | | | | | 6,319,000 | | 4,261,000 | 4,025,000 | | 1,701,000 | | | | | 964,000 | | 383,000 | 454,000 | | 0 | | | | | | | | |
Restricted Stock Units and Performance Shares Outstanding [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Number of shares outstanding | | | | | | | | | 555,000 | 0 | 638,000 | 0 | | | | | | | | | | | | | | | | | 6,319,000 | | 4,261,000 | 4,025,000 | | 1,701,000 | | | | | 964,000 | | 383,000 | 454,000 | | 0 | | | | | | | | |
Number of shares vested and expected to vest | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 4,978,000 | | | 3,083,000 | | | | | | | 801,000 | | | 369,000 | | | | | | | | | | |
Outstanding weighted average remaining contractual life | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.7 | | | 1.91 | | | | | | | 1.3 | | | 1.44 | | | | | | | | | | |
Vested and expected to vest weighted average remaining contractual life | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.52 | | | 1.69 | | | | | | | 1.21 | | | 1.34 | | | | | | | | | | |
Outstanding intrinsic value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 200,500,000 | [4] | | 172,400,000 | [4] | | | | | | 30,600,000 | [5] | | 19,400,000 | [5] | | | | | | | | | |
Vested and expected to vest intrinsic value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 157,800,000 | [4] | | 132,000,000 | [4] | | | | | | 25,300,000 | [5] | | 15,800,000 | [5] | | | | | | | | | |
Performance Share Activity 2009 Program [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning outstanding balance | | | | | | | | | 0 | | 0 | | | | | | | | | | | | | | | | | | 4,261,000 | | 1,701,000 | | | | | | | | 383,000 | | 0 | | | | | | | | | | | |
Awarded | | | | | | | | | 558,000 | | 642,000 | | | | | | | | | | | | | | | | | | 3,333,000 | | 3,177,000 | | | | | | | | | | | | | | | | | | | | | |
Forfeited | | | | | | | | | (3,000) | | (4,000) | | | | | | | | | | | | | | | | | | (291,000) | | (195,000) | | | | | | | | (59,000) | | (130,000) | | | | | | | | | | | |
Ending outstanding balance | | | | | | | | | 555,000 | 0 | 638,000 | 0 | | | | | | | | | | | | | | | | | 6,319,000 | | 4,261,000 | 4,025,000 | | 1,701,000 | | | | | 964,000 | | 383,000 | 454,000 | | 0 | | | | | | | | |
Performance Share Activity Prior Years Programs [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning outstanding balance | | | | | | | | | 0 | | 0 | | | | | | | | | | | | | | | | | | 4,261,000 | | 1,701,000 | | | | | | | | 383,000 | | 0 | | | | | | | | | | | |
Achieved | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1,022,000 | | 993,000 | | | | | | | | | | | |
Released | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (984,000) | | (422,000) | | | | | | | | (382,000) | | (480,000) | | | | | | | | | | | |
Forfeited | | | | | | | | | (3,000) | | (4,000) | | | | | | | | | | | | | | | | | | (291,000) | | (195,000) | | | | | | | | (59,000) | | (130,000) | | | | | | | | | | | |
Ending outstanding balance | | | | | | | | | 555,000 | 0 | 638,000 | 0 | | | | | | | | | | | | | | | | | 6,319,000 | | 4,261,000 | 4,025,000 | | 1,701,000 | | | | | 964,000 | | 383,000 | 454,000 | | 0 | | | | | | | | |
Total Stock-based Compensation Costs [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenue-services and support | | | | | | | | | | | | | 437,000 | [2] | 1,189,000 | [2] | 1,595,000 | [1] | 2,968,000 | [1] | 190,000 | [2] | 230,000 | [2] | 527,000 | [1] | 483,000 | [1] | | | | | | | | | | | | | | | | | | | | | | | | |
Research and development | | | | | | | | | | | | | 11,922,000 | [2] | 15,612,000 | [2] | 35,317,000 | [1] | 43,382,000 | [1] | 6,338,000 | [2] | 6,377,000 | [2] | 21,271,000 | [1] | 16,380,000 | [1] | | | | | | | | | | | | | | | | | | | | | | | | |
Sales and marketing | | | | | | | | | | | | | 9,100,000 | [2] | 10,576,000 | [2] | 27,681,000 | [1] | 31,701,000 | [1] | 4,730,000 | [2] | 5,370,000 | [2] | 14,565,000 | [1] | 15,558,000 | [1] | | | | | | | | | | | | | | | | | | | | | | | | |
General and administrative | | | | | | | | | | | | | 4,938,000 | [2] | 6,113,000 | [2] | 19,220,000 | [1] | 18,841,000 | [1] | 2,087,000 | [2] | 2,793,000 | [2] | 6,962,000 | [1] | 10,368,000 | [1] | | | | | | | | | | | | | | | | | | | | | | | | |
Total | | | | | | | | | | | | | 26,397,000 | [2] | 33,490,000 | [2] | 83,813,000 | [1] | 96,892,000 | [1] | 13,345,000 | [2] | 14,770,000 | [2] | 43,325,000 | [1] | 42,789,000 | [1] | | | | | | | | | | | | | | | | | | | | | | | | |
Stock Based Compensation Numeric [Abstract] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Unrecognized compensation cost, adjusted for estimated forfeitures, related to non-vested stock based awards, will be recognized in 2.5 years | | | 225,400,000 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Period over which unrecognized compensation costs will be recognized | | | 2.5 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash Recoveries of Fringe Benefit Tax, India | 100,000 | 2,100,000 | 900,000 | 2,100,000 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual shares achieved for the 2008 Program | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1,000,000 |
Actual percentage achieved for the 2008 Program | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.24 |
Percentage vesting on the later of the date of certification of achievement or the first anniversary date of the grant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 0.25 | 0.25 |
Percentage vesting evenly on following three annual anniversary dates of the grant, contingent upon the recipient's continued service to Adobe | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 0.75 | 0.75 |
Maximum percentage of target shares able to receive | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.15 | 2 |
Weighted Average Fair Value of Shares, ESPP | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 5.4 | 9.03 | | | | | | | | | | | | | | |
Shares Purchased, ESPP | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 3,200,000 | 2,400,000 | | | | | | | | | | | | | | |
Average shares Purchase Price, ESPP | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 19.04 | 30.4 | | | | | | | | | | | | | | |
Shares Purchased Intrinsic Value, ESPP | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 21,700,000 | 25,000,000 | | | | | | | | | | | | | | |
Closing market values | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 31.73 | | | 42.83 | | | | | | | 31.73 | | | 42.83 | | | 31.73 | | | 42.83 | | | | |
[1]For the nine months ended August 28, 2009 and August 29, 2008, we recorded $0.9 million and $2.1 million, respectively, associated with cash recoveries of fringe benefit tax from employees in India | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2]For the three months ended August 28, 2009 and August 29, 2008, we recorded $0.1 million and $2.1 million, respectively, associated with cash recoveries of fringe benefit tax from employees in India. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[3]The intrinsic value is calculated as the difference between the market value as of the end of the fiscal period and the exercise price of the shares. As reported by the NASDAQ Global Select Market, the market values as of August 28, 2009 and August 29, 2008 were $31.73 and $42.83, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[4]The intrinsic value is calculated as the market value as of the end of the fiscal period. As reported by the NASDAQ Global Select Market, the market values as of August 28, 2009 and August 29, 2008 were $31.73 and $42.83, respectively | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[5]The intrinsic value is calculated as the market value as of the end of the fiscal period. As reported by the NASDAQ Global Select Market, the market values as of August 28, 2009 and August 29, 2008 were $31.73 and $42.83, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |